BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Biotech Bay

  Annexon Raises $100 Million to Advance Therapies for Neurodegenerative, Autoimmune Disorders

  Annexon, based in South San Francisco, closed on a $100 million Series C financing led by Redmile Group.

  July 2, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Helsinn and MEI Discontinue Phase III Trial of Pracinostat in AML

  The decision was made after an interim futility analysis by an Independent Data Monitoring Committee determined the trial was unlikely to meet the primary endpoint of overall survival (OS) compared to the control group.

  July 2, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Clinical Catch-Up: June 29-July 3

  Heading into the 4th of July holiday in the U.S., there was still a fair amount of clinical trial news last week. Here’s a look.

  July 2, 2020

   · 

  7 min read

   · 

  Mark Terry
• 

  Business

  AGTC Boosts AAV Manufacturing Productivity with Herpes Simplex Virus

  By using the herpes simplex virus (HSV) as a helper for its adeno-associated viral (AAV) platform, Applied Genetic Technologies Corporation (AGTC) created AAVs that are more robust, purer and lower cost than any of the other methods.

  July 2, 2020

   · 

  4 min read

   · 

  Gail Dutton
• 

  Biotech Bay

  New Data Shows Promise Involving Lenacapavir for the Treatment of HIV

  A study published in the journal Nature on July 1 suggests that there may be a new way to target an HIV protein called capsid, which was almost unmanageable in patients until now.

  July 2, 2020

   · 

  2 min read

   · 

  Krystle Vermes
• 

  Drug Development

  Report: Moderna’s Phase III COVID-19 Vaccine Trial Delayed

  It’s not clear how long the trial will be delayed, but according to a report by STAT, it may still begin in July.

  July 2, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Tesla to Build Mobile RNA Microfactories for CureVac’s COVID-19 Vaccine

  The “printers” are portable, automated messenger RNA (mRNA) production units, which Elon Musk referred to as “RNA microfactories.”

  July 2, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  COVID-19 Vaccine: Behind the Scenes of Moderna, the Company Leading the Way

  Moderna has always been an odd and secretive company. Currently all eyes are on the company because it is the furthest along in developing a vaccine against COVID-19.

  July 2, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  Genetown

  Amylyx to Continue Pioneering New Treatments for Neurodegenerative Diseases with $30M in Funding

  Massachusetts-based Amylyx Pharmaceuticals, a company focused on developing new treatments for neurodegenerative diseases, announced today that it had concluded a $30 million Series B round of financing.

  July 2, 2020

   · 

  3 min read

   · 

  Krystle Vermes
• 

  Career Advice

  How to Make a Career Change Later in Life

  Many people stepping into middle age feel that they’re too old to make a career change, but we live in times when an average person changes up to 12 jobs in a lifetime.

  July 2, 2020

   · 

  3 min read

   · 

  Jim Raychrudhury